Zebularine showed anti-tumor efficacy in clear cell renal cell carcinoma

BackgroundClear cell renal cell carcinoma (ccRCC) has the highest morbidity among renal cell carcinoma (RCC) subtypes. While existing clinical pharmacological intervention strategies have achieved certain efficacy, challenges including inevitable drug resistance and intricate immune heterogeneity of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Haoyu Xu, Senlin Peng, Junwu Li, Yuanyuan Bai, Guozhi Zhao, Simin Liang, Wei Tang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-02-01
coleção:	Frontiers in Pharmacology
Assuntos:	clear cell renal cell carcinoma immune-related prognostic index immunological profiling drug screening network pharmacology molecular docking
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1531056/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!